User talk:Hofland

Disambiguation link notification
Hi. When you recently edited Brivanib alaninate, you added links pointing to the disambiguation pages Moiety and FGF (check to confirm | fix with Dab solver). Such links are almost always unintended, since a disambiguation page is merely a list of "Did you mean..." article titles. Read the FAQ* Join us at the DPL WikiProject.

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, DPL bot (talk) 18:52, 19 February 2012 (UTC)

Thanks for the update and changing the reference style!

The Wikipedia Library now offering accounts from Cochrane Collaboration (sign up!)
Cochrane Collaboration is an independent medical nonprofit organization consisting of over 28,000 volunteers in more than 100 countries. The collaboration was formed to organize medical scholarship in a systematic way in the interests of evidence-based research: the group conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.

Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account. Thank you Cochrane!

If you are stil active as a medical editor, come and sign up :)

Cheers, Ocaasit &#124; c 20:04, 16 June 2013 (UTC)

Request to reinstate
ADC Review / Journal of Antibody-drug Conjugates is a relevant - non promotional entry. The content of this page is as informative as any of the other pages related to real publications. It is a neutral page without advertising - and should be treated as any other page discussing medical (publications.

Speedy deletion nomination of ADC Review / Journal of Antibody Drug Conjugates


A tag has been placed on ADC Review / Journal of Antibody Drug Conjugates, requesting that it be speedily deleted from Wikipedia. This has been done under section G11 of the criteria for speedy deletion, because the page seems to be unambiguous advertising which only promotes a company, product, group, service or person and would need to be fundamentally rewritten in order to become encyclopedic. Please read the guidelines on spam and FAQ/Organizations for more information.

If you think this page should not be deleted for this reason, you may contest the nomination by visiting the page and clicking the button labelled "Click here to contest this speedy deletion". This will give you the opportunity to explain why you believe the page should not be deleted. However, be aware that once a page is tagged for speedy deletion, it may be removed without delay. Please do not remove the speedy deletion tag from the page yourself, but do not hesitate to add information in line with Wikipedia's policies and guidelines. If the page is deleted, and you wish to retrieve the deleted material for future reference or improvement, you can place a request here. Randykitty (talk) 16:12, 29 June 2013 (UTC)

June 2013
Hello, Hofland. We welcome your contributions to Wikipedia, but if you are affiliated with some of the people, places or things you have written about in the article ADC Review / Journal of Antibody Drug Conjugates, you may have a conflict of interest or close connection to the subject.

All editors are required to comply with Wikipedia's neutral point of view content policy. People who are very close to a subject often have a distorted view of it, which may cause them to inadvertently edit in ways that make the article either too flattering or too disparaging. People with a close connection to a subject are not absolutely prohibited from editing about that subject, but they need to be especially careful about ensuring their edits are verified by reliable sources and writing with as little bias as possible.

If you are very close to a subject, here are some ways you can reduce the risk of problems:


 * Avoid or exercise great caution when editing or creating articles related to you, your organization, or its competitors, as well as projects and products they are involved with.
 * Be cautious about deletion discussions. Everyone is welcome to provide information about independent sources in deletion discussions, but avoid advocating for deletion of articles about your competitors.
 * Avoid linking to the Wikipedia article or website of your organization in other articles (see Spam).
 * Exercise great caution so that you do not accidentally breach Wikipedia's content policies.

Please familiarize yourself with relevant content policies and guidelines, especially those pertaining to neutral point of view, verifiability of information, and autobiographies.

For information on how to contribute to Wikipedia when you have a conflict of interest, please see our frequently asked questions for organizations. Thank you. Randykitty (talk) 16:13, 29 June 2013 (UTC)

Proposed deletion of ADC Review / Journal of Antibody Drug Conjugates


The article ADC Review / Journal of Antibody Drug Conjugates has been proposed for deletion&#32; because of the following concern:
 * New journal, has not yet had time to become notable. Article creation vastly premature. No independent references, not included in any selective major databases. Does not meet WP:GNG or WP:NJournals.

While all constructive contributions to Wikipedia are appreciated, content or articles may be deleted for any of several reasons.

You may prevent the proposed deletion by removing the notice, but please explain why in your edit summary or on the article's talk page.

Please consider improving the article to address the issues raised. Removing will stop the proposed deletion process, but other deletion processes exist. In particular, the speedy deletion process can result in deletion without discussion, and articles for deletion allows discussion to reach consensus for deletion. Randykitty (talk) 05:43, 30 June 2013 (UTC)

Nomination of ADC Review / Journal of Antibody Drug Conjugates for deletion
A discussion is taking place as to whether the article ADC Review / Journal of Antibody Drug Conjugates is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/ADC Review / Journal of Antibody Drug Conjugates until a consensus is reached, and anyone is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Randykitty (talk) 08:00, 30 June 2013 (UTC)

Your recent edits
Hello and welcome to Wikipedia. When you add content to talk pages and Wikipedia pages that have open discussion (but never when editing articles), please be sure to sign your posts. There are two ways to do this. Either: This will automatically insert a signature with your username or IP address and the time you posted the comment. This information is necessary to allow other editors to easily see who wrote what and when.
 * 1) Add four tildes  ( &#126;&#126;&#126;&#126; ) at the end of your comment; or
 * 2) With the cursor positioned at the end of your comment, click on the signature button (Insert-signature.png or Signature icon.png) located above the edit window.

Thank you. --SineBot (talk) 15:29, 30 June 2013 (UTC)

December 2013
Hello, I'm BracketBot. I have automatically detected that [//en.wikipedia.org/w/index.php?diff=586555688 your edit] to Brentuximab vedotin may have broken the syntax by modifying 1 ""s and 1 "[]"s likely mistaking one for another. If you have, don't worry: just [ edit the page] again to fix it. If I misunderstood what happened, or if you have any questions, you can leave a message on [//en.wikipedia.org/w/index.php?action=edit&preload=User:A930913/BBpreload&editintro=User:A930913/BBeditintro&minor=&title=User_talk:A930913&preloadtitle=BracketBot%20–%20&section=new my operator's talk page].
 * List of unpaired brackets remaining on the page:

Thanks, BracketBot (talk) 22:24, 17 December 2013 (UTC)
 * Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, Study Shows] December 10, 2013.

Disambiguation link notification for January 4
Hi. Thank you for your recent edits. Wikipedia appreciates your help. We noticed though that when you edited Grünenthal GmbH, you added a link pointing to the disambiguation page Stolberg (check to confirm | fix with Dab solver). Such links are almost always unintended, since a disambiguation page is merely a list of "Did you mean..." article titles. Read the FAQ* Join us at the DPL WikiProject.

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, DPL bot (talk) 09:03, 4 January 2014 (UTC)

The page has been updated! Thanks for your help!

Refs
Please use high quality secondary sources per WP:MEDRS. Thanks Doc James  (talk · contribs · email) (if I write on your page reply on mine) 11:29, 12 April 2014 (UTC)

ArbCom elections are now open!
MediaWiki message delivery (talk) 16:38, 23 November 2015 (UTC)

Disambiguation link notification for January 15
Hi. Thank you for your recent edits. Wikipedia appreciates your help. We noticed though that when you edited Pyrrolobenzodiazepine, you added a link pointing to the disambiguation page AML. Such links are almost always unintended, since a disambiguation page is merely a list of "Did you mean..." article titles. Read the FAQ* Join us at the DPL WikiProject.

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, DPL bot (talk) 09:18, 15 January 2016 (UTC)

Your edits look like blatant attempt to promote adcreview
eg your edits to Vadastuximab talirine (SGN-CD33A). Also - it would be helpful if you could provide edit summaries for your edits. - Rod57 (talk) 12:12, 2 March 2016 (UTC)

Your draft article, User:Hofland/ADC Review / Journal of Antibody Drug Conjugates


Hello, Hofland. It has been over six months since you last edited the Articles for Creation submission or Draft page you started, "ADC Review / Journal of Antibody Drug Conjugates".

In accordance with our policy that Wikipedia is not for the indefinite hosting of material deemed unsuitable for the encyclopedia mainspace, the draft has been nominated for deletion. If you plan on working on it further, or editing it to address the issues raised if it was declined, simply and remove the, , or  code.

If your submission has already been deleted by the time you get there, and you wish to retrieve it, you can request its undeletion by following the instructions at this link. An administrator will, in most cases, restore the submission so you can continue to work on it.

Thank you for your submission to Wikipedia! MrLinkinPark333 (talk) 19:35, 26 February 2020 (UTC)

Copyright problem: Polatuzumab vedotin
Hello, and welcome to Wikipedia! We welcome and appreciate your contributions, such as Polatuzumab vedotin, but we regretfully cannot accept copyrighted text or images from either web sites or printed works. This article appears to contain work copied from https://www.adcreview.com/copyright-creative-commons/, and therefore to constitute a violation of Wikipedia's copyright policies. The copyrighted text has been or will soon be deleted. While we appreciate contributions, we must require all contributors to understand and comply with our copyright policy. Wikipedia takes copyright violations very seriously, and persistent violators are liable to be blocked from editing.

If you believe that the article is not a copyright violation, or if you have permission from the copyright holder to release the content freely under license allowed by Wikipedia, then you should do one of the following:

It may also be necessary for the text to be modified to have an encyclopedic tone and to follow Wikipedia article layout. For more information on Wikipedia's policies, see Wikipedia's policies and guidelines.
 * Have the author release the text under the Creative Commons Attribution-ShareAlike 3.0 License (CC BY-SA 3.0) by leaving a message explaining the details at Talk:Polatuzumab vedotin and send an email with confirmation of permission to "permissions-en (at) wikimedia (dot) org". Make sure they quote the exact page name, Polatuzumab vedotin, in their email. See Requesting copyright permission for instructions.
 * If you hold the copyright to the work: send an e-mail from an address associated with the original publication to permissions-en(at)wikimedia(dot)org or a postal message to the Wikimedia Foundation permitting re-use under the Creative Commons Attribution-ShareAlike 3.0 License and GNU Free Documentation License, and note that you have done so on Talk:Polatuzumab vedotin. See Donating copyrighted materials for instructions.
 * If a note on the original website states that re-use is permitted "under the Creative Commons Attribution-ShareAlike License (CC-BY-SA), version 3.0", or that the work is released into the public domain, or if you have strong reason to believe it is, leave a note at Talk:Polatuzumab vedotin with a link to where we can find that note or your explanation of why you believe the content is free for reuse.

See Declaration of consent for all enquiries for a template of the permissions letter the copyright holder is expected to send.

If you would like to begin working on a new version of the article you may do so at [ this temporary page]. Leave a note at Talk:Polatuzumab vedotin saying you have done so and an administrator will move the new article into place once the issue is resolved.

Thank you, and please feel welcome to continue contributing to Wikipedia. Happy editing! ἀνυπόδητος (talk) 12:36, 28 February 2020 (UTC)

Copyright warning
Your edit to CBR96-doxorubicin immunoconjugate has been removed in whole or in part, as it appears to have added copyrighted material to Wikipedia without evidence of permission from the copyright holder. If you are the copyright holder, please read Donating copyrighted materials for more information on uploading your material to Wikipedia. For legal reasons, Wikipedia cannot accept copyrighted material, including text or images from print publications or from other websites, without an appropriate and verifiable license. All such contributions will be deleted. You may use external websites or publications as a source of information, but not as a source of content, such as sentences or images&mdash;you must write using your own words. Wikipedia takes copyright very seriously, and persistent violators of our copyright policy will be blocked from editing. See Copying text from other sources for more information. --MrLinkinPark333 (talk) 00:49, 5 April 2022 (UTC)